FuturedMe is a pioneer in the science of using CANDDY™ Platform—new protein degradation platform—to make new small molecules as drug candidates
FuturedMe is a pioneer in the science of using CANDDY™ Platform—new protein degradation platform—to make new small molecules as drug candidates. CANDDY™ technology has invented by Tokyo University of Science, professor Etsuko Miyamoto-Sato. CANDDY™ is a ubiquitin-INDEPENDENT and direct proteasomal degradation technology, which can break down proteins of interest using the cell’s natural protein degradation machinery rather than merely inhibiting the function of the proteins, as traditional drugs